Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06442891 · ClinicalTrials.gov registry record · NA

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

A NA study, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT06442891 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 42 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06442891, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

This clinical trial tests the feasibility of self-administered relaxing acupressure on fatigue in adolescent and young adult (AYA) cancer survivors. Acupressure, a type of complementary or alternative medicine, is the application of pressure or localized massage to specific sites on the body to control symptoms. Relaxing acupressure has been shown to improve cancer-related fatigue (CRF) in adults, however, less is known about the impact of relaxing acupressure on CRF in AYA cancer survivors."

Interventions

  • OTHER Questionnaire Administration
  • OTHER Interview
  • PROCEDURE Acupressure Therapy
  • OTHER Internet-Based Intervention

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2024-10-01
Est. Completion 2025-12-22
Phase NA

What the Registry Record Tells You About NCT06442891

The ClinicalTrials.gov registry entry for NCT06442891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT06442891 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06442891 about?

NCT06442891 is a clinical study titled "Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors". This clinical trial tests the feasibility of self-administered relaxing acupressure on fatigue in adolescent and young adult (AYA) cancer survivors. Acupressure, a type of complementary or alternative medicine, is the application of pressure or localized massage to specific sites on the body to cont...

What is the current status of trial NCT06442891?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2024-10-01. Estimated completion is 2025-12-22.

What interventions are being tested in trial NCT06442891?

The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Acupressure Therapy (PROCEDURE), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT06442891?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.